Chemours Co Quarterly Income Tax Expense (Benefit) in USD from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Chemours Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2014 to Q2 2024.
  • Chemours Co Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $12M.
  • Chemours Co Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$25M, a 143% decline year-over-year.
  • Chemours Co annual Income Tax Expense (Benefit) for 2023 was -$81M, a 150% decline from 2022.
  • Chemours Co annual Income Tax Expense (Benefit) for 2022 was $163M, a 140% increase from 2021.
  • Chemours Co annual Income Tax Expense (Benefit) for 2021 was $68M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$25M $12M +$69M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$94M $15M -$13M -46.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 -$81M -$53M -$81M -289% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $0 $1M -$58M -98.3% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-27
Q2 2023 $58M -$57M -$87M -290% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $145M $28M -$18M -39.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $163M $28M -$40M -58.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $203M $59M +$42M +247% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $161M $30M +$52M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $109M $46M +$41M +820% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $68M $68M +$65M +2167% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 $3M $17M +$33M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$30M -$22M -$18M -450% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 -$12M $5M +$28M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$40M $3M +$140M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 -$180M -$16M -$31M -207% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$149M -$4M -$41M -111% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$108M -$23M -$36M -277% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$72M -$137M -$177M -443% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $105M $15M +$21M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $84M $37M -$4M -9.76% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $88M $13M -$71M -84.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $159M $40M +$4M +11.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $155M -$6M -$49M -114% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $204M $41M -$23M -35.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $227M $84M +$62M +282% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $165M $36M +$80M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $85M $43M +$13M +43.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $72M $64M +$87M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$15M $22M +$3M +15.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$18M -$44M -$9M -25.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 -$9M $30M +$108M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$117M -$23M -$23M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$94M $19M +$4M +26.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$98M -$35M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 -$78M -$113M -323% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $0 -$39M -100% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $15M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 $35M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $39M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.